- Motley Fool•yesterday
Did you just get a refund check from Uncle Sam? Here are three stocks you should consider buying with those funds.
- Investor's Business Daily•2 days ago
Wall Street will be keyed in Tuesday to Biogen's earnings for a first look at whether payer pushback hindered sales of Spinraza.
- American City Business Journals•2 days ago
Juno Therapeutics Inc. has added Celgene Corp. President of Research and Early Development Dr. Rupert Vessey to the Seattle-based biotech's board. Vessey will serve as as Celgene's designated appointee to Juno's board, replacing Dr. Tom Daniel, who retired last summer but will remain on the board as an independent contractor. Juno (JUNO) inked a $1 billion collaboration with Celegene in 2015.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||122.16 x 200|
|Ask||123.00 x 600|
|Day's Range||121.71 - 123.70|
|52 Week Range||94.42 - 127.64|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||49.10|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|